FibroGen
FGEN
FGEN
171 hedge funds and large institutions have $1.42B invested in FibroGen in 2023 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 48 increasing their positions, 60 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
19% more funds holding
Funds holding: 144 → 171 (+27)
0.06% more ownership
Funds ownership: 3.19% → 3.24% (+0.06%)
20% less repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 60
Holders
171
Holding in Top 10
2
Calls
$41.6M
Puts
$7.94M
Top Buyers
| 1 | +$25.2M | |
| 2 | +$25.1M | |
| 3 | +$23.6M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$17.9M |
| 5 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$11.1M |
Top Sellers
| 1 | -$33.6M | |
| 2 | -$29M | |
| 3 | -$25.3M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$12.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$11.4M |